We would love to connect with you during the DIA and discuss how we can support you to optimise your path to market approval.
Working together we can:
- Accelerate your drug development program to reduce your time to approval
- Optimise the management of the regulatory process to provide accurate and predictable outcomes
- Reduce your risks and increase the probability of gaining Market Authorization
Don't miss our great speakers sharing their knowledge in different forums throughout the conference:
Dr Steffen Thirstrup - NDA Advisory Board Director & John Ellis, Communications Coach, PharmApprove, NDA Group
A tutorial on Tuesday, June 22 • 09:30 – 12:30 EDT – Tutorial (Short Course)
Shelley Gandhi, Patient Safety & Pharmacovigilance Director, NDA Group
A session on 17th June • 13:00 -14:00 EDT On-Demand and will be available anytime for viewing
OD: Safety Compliance
Dr Brian Edwards, Principal Consultant, NDA Group
Two Sessions - Semi-Live and will include live Q&A with our Speakers.
Monday, June 28 • 16:00 - 17:00 EDT
#SL: A Journey of Interdisciplinary Collaboration to Improve Safety Evaluation in Drug Development
Tuesday, June 29 • 14:00 - 15:00 EDT
Click here to download the full programme.